MedMira Inc. (FRA:47M)

Market Cap	32.38M
Revenue (ttm)	151.92K
Net Income (ttm)	-2.86M
Shares Out	n/a
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	676
Open	0.0390
Previous Close	0.0350
Day's Range	0.0390 - 0.0390
52-Week Range	0.0340 - 0.0775
Beta	n/a
RSI	36.13
Earnings Date	Nov 28, 2025

About MedMira

MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV ...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1993
• Employees: 52
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 47M

Financial Performance

In 2025, MedMira's revenue was 240,509, a decrease of -41.70% compared to the previous year's 412,568. Losses were -4.52 million, 36.0% more than in 2024.

Financial numbers in CAD